Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Interest Expense
Cost of servicing the company's debt during the period.
Interest Expense history
Currency unavailable · from the income statement
No Interest Expense data reported for this period type.
Interest Expense vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $81.34M USD | -4.8% | +46.9% | 7.1% | |
| LTM Mar 2026 | $39.11M USD | -0.6% | -17.7% | 10.8% | |
VCREVicore Pharma Holding AB | LTM Jun 2026 | SEK 9.19M SEK | -77.5% | +95.7% | 691.0% |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | -4.8% | +46.9% | 9.0% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.